Helaina, founded in 2019 by Laura Katz and headquartered in New York, is dedicated to creating superior breast milk alternatives for modern parents. The company's core mission is to support parents with breastfeeding by providing advanced nutritional solutions. Helaina utilizes a technology platform that replicates functional proteins found in the human body, making them available as new nutrients. Their flagship product, Effera™ Human Lactoferrin, mimics the highly concentrated lactoferrin found in human colostrum, playing a crucial role in health optimization.

Notable figures associated with Helaina include founder Laura Katz, who has been instrumental in driving the company's vision. The startup has attracted significant attention from investors focused on health and nutrition innovation. Key achievements include successful preclinical and clinical studies demonstrating the efficacy of their products. Helaina's impact lies in its potential to revolutionize infant nutrition by providing scientifically advanced alternatives to traditional breast milk, addressing the needs of modern parenting.